Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 12/20 | 0.68 |
| ▸ | CA1 | P00915 | 12/20 | 0.68 |
| ▸ | CA9 | Q16790 | 10/20 | 0.68 |
| ▸ | CDK2 | P24941 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | CA12 | O43570 | 6/20 | 0.47 |
| ▸ | CA6 | P23280 | 3/20 | 0.47 |
| ▸ | CA4 | P22748 | 2/20 | 0.47 |
| ▸ | CA5A | P35218 | 2/20 | 0.47 |
| ▸ | CA7 | P43166 | 2/20 | 0.47 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | LDHA | P00338 | 1/20 | 0.46 |
| ▸ | ATIC | P31939 | 1/20 | 0.44 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28055479 | 0.85 | CA1 (0.55) | CA2CA1CA9CDK2KDM4E | |
| SCHEMBL3768625 | 0.83 | HTR6 (0.46) | CA2CA1CA9CDK2KDM4E | |
| SCHEMBL660554 | 0.82 | ALDH1A1 (0.44) | CA2CA1CA9CDK2KDM4E | |
| SCHEMBL29623319 | 0.82 | TTR (0.50) | CA2CA1CA9CDK2KDM4E | |
| SCHEMBL155232 | 0.82 | TTR (0.50) | CA2CA1CA9CDK2KDM4E | |
| Anthracene SCHEMBL27538789 | 0.82 | TTR (0.50) | CA2CA1CA9CDK2KDM4E | |
| SCHEMBL29529240 | 0.81 | CA2 (1.00) | CA2CA1CA9CDK2KDM4E | |
| SCHEMBL28464 | 0.81 | CA2 (1.00) | CA2CA1CA9CDK2KDM4E | |
| Acridine SCHEMBL28003717 | 0.80 | CA2 (0.58) | CA2CA1CA9CDK2KDM4E | |
| SCHEMBL725590 | 0.80 | ALDH1A1 (0.43) | CA2CA1CA9CDK2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025034531-A1 | SMALL MOLECULE ALLOSTERIC MODULATOR TO PAC1 RECEPTOR AND USES THEREOF | THE UNIVERSITY OF VERMONT AND STATE AGRICULTURAL COLLEGE (US) | 2025-02-13 | — | — | WO | disclosed |
| WO-2023168066-A9 | OXIME-BASED HOT MELT ADHESIVES FOR REWORK, REPAIR AND RECYCLE | CONAGEN INC. (US) | 2024-06-20 | — | — | WO | disclosed |
| EP-4362920-A1 | COMPOSITIONS FOR DELIVERY OF MRNA | Translate Bio, Inc. (US) | 2024-05-08 | — | — | EP | disclosed |
| EP-4359380-A1 | PROCESSES FOR THE PREPARATION OF (S)-2-(2,6-DIOXOPIPERIDIN-3-YL)-4-((2-FLUORO-4-((3-MORPHOLINOAZETIDIN-1-YL) METHYL)BENZYL) AMINO)ISOINDOLINE-1,3-DIONE | Celgene Corporation (US) | 2024-05-01 | — | — | EP | disclosed |
| WO-2024086705-A2 | BICYCLIC ENHANCERS OF THE PARTICULATE GUANYLYL CYCLASE RECEPTOR A | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2024-04-25 | — | — | WO | disclosed |
| WO-2024073745-A1 | INHIBITORS OF EGFR OR HER2 AND METHODS OF USE | ARBELLA THERAPEUTICS, LLC (US) | 2024-04-04 | — | — | WO | disclosed |
| WO-2024026353-A2 | ENZYMATIC SYNTHESIS OF MYCOSPORINE-LIKE AMINO ACIDS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2024-02-01 | — | — | WO | disclosed |
| WO-2023168066-A1 | OXIME-BASED HOT MELT ADHESIVES FOR REWORK, REPAIR AND RECYCLE | CONAGEN INC. (US) | 2023-09-07 | — | — | WO | disclosed |
| EP-4225322-A1 | N-ACETYLGALACTOSAMINE(GALNAC)-DERIVED COMPOUNDS AND OLIGONUCLEOTIDES | Adarx Pharmaceuticals, Inc. (US) | 2023-08-16 | — | — | EP | disclosed |
| WO-2023114188-A1 | IONIZABLE LIPIDS AND COMPOSITIONS AND USES THEREOF | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2023-06-22 | — | — | WO | disclosed |
| EP-0912504-B1 | Oxazolidine ester | UPJOHN CO (US) | 2002-09-11 | — | — | EP | disclosed |
| US-6307064-B1 | PHENYLISOSERINE ESTER OF SILYLATED BACCATIN III | PHARMACIA & UPJOHN COMPANY | 2001-10-23 | — | — | US | disclosed |
| EP-1114815-A2 | Process to prepare taxol | PHARMACIA & UPJOHN COMPANY (US) | 2001-07-11 | — | — | EP | disclosed |
| US-6177573-B1 | Process to prepare taxol | PHARMACIA & UPJOHN COMPANY | 2001-01-23 | — | — | US | disclosed |
| US-6057452-A | Process to prepare taxol | PHARMACIA & UPJOHN COMPANY | 2000-05-02 | — | — | US | disclosed |
| EP-0912504-A1 | PROCESS TO PREPARE TAXOL | PHARMACIA & UPJOHN COMPANY (US) | 1999-05-06 | — | — | EP | disclosed |
| CN-1216039-A | Process for preparing taxol | UPJOHN CO (US) | 1999-05-05 | — | — | CN | disclosed |
| WO-1997042167-A1 | PROCESS TO PREPARE TAXOL | PHARMACIA & UPJOHN COMPANY (US) | 1997-11-13 | — | — | WO | disclosed |
| US-5679769-A | SOLID PHASE SYNTHESIS OF OLIGOSACCHARIDES-OLIGOPEPTIDES; ANTICARCINOGENIC AGENTS | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1997-10-21 | — | — | US | disclosed |
| WO-1996040198-A1 | SYNTHESIS OF ASPARAGINE-LINKED GLYCOPEPTIDES ON A POLYMERIC SOLID SUPPORT | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1996-12-19 | — | — | WO | disclosed |